PR Newswire
20 Nov 2023, 09:09 GMT+10
The company will be presenting its growing pipeline of superb technologies for treating all four heart valves in its booth and at multiple events during the conference.
HANGZHOU, China, Nov. 20, 2023 /PRNewswire/ -- Venus Medtech is changing how the world treats structural heart disease. The company will present its products at its booth (#28), during two symposia, in multiple podium presentations and at a special cocktail reception where it will officially launch the SMART-ALIGN multicenter clinical study.
Structural heart symposia on November 20 and 21
The company will be hosting two symposia on November 20 and 21 that will allow interventional cardiologists to deepen their knowledge about structural heart interventions. The first, "Valve tricuspid Transcatheter: Cardiovalve keeps it in motion" will be dedicated to discussing the latest results and future plans for the Cardiovalve tricuspid valve replacement system. In the second, "Addressing remaining issues after TAVI: What to expect from the new generation," presenters will focus on the tools and techniques showcasing the Venus Vitae.
Launching the SMART-ALIGN Study with registration studies commencing annually
Additionally, Venus will be officially launching the SMART-ALIGN study to evaluate the performance of the Venus-Vitae Transcatheter Heart Valve System in patients with severe aortic stenosis. The study will enroll 150 patients at 20 medical centers worldwide. This new study builds on the TARGET study launched at London Valves 2022, which is evaluating the Cardiovalve system for transcatheter tricuspid valve replacement. Cardiovalve is now on track for CE mark approval in late 2026, with about half of the patients already enrolled. Prior to this, Venus Medtech achieved significant success with its Pvalve system replacing the pulmonary valve, securing CE approval in 2022 and planning for an FDA registration study in 2024. These studies are a testament to Venus Medtech's mission, consistently improving the treatment of structural heart disease.
About Venus Medtech
Venus Medtech (Hangzhou) Inc. (2500.HK) is committed to structural heart innovation. We are developing and commercializing comprehensive solutions for structural heart disease. Our robust pipeline, encompassing all four heart valves from TAVR, TPVR, TMVR, and TTVR to hypertrophic cardiomyopathy and hypertensive renal denervation (RDN) therapy, underscores our unwavering commitment.
For more information, please visit https://venusmedtechconference.com/
Get a daily dose of Vietnam Tribune news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Vietnam Tribune.
More InformationJAKARTA, Indonesia: The death toll from the eruption of Indonesia's Marapi volcano surged to 22 as rescuers discovered additional climbers ...
DHAKA, Bangladesh - PM Sheikh Hasina is ranked 46th on Forbes' list of the World's 100 Most Powerful Women in ...
LAHORE, Pakistan - According to the Lahore police Organized Crime Unit (OCU), a gang of robbers has been arrested in ...
BUKITTINGGI, Indonesia: On December 2, Mount Marapi in West Sumatra province, Indonesia, erupted, sending hot ash clouds several miles (kilometers) ...
NAYPYITAW, Myanmar - Myanmar's junta chief has urged ethnic armed groups fighting the military across the country to find a ...
DHAKA, Bangladesh - Bangladesh's father of cardiology, Professor Brigadier (retd) Abdul Malik, who established the first cardiac unit in Bangladesh ...
In September, Tamir Pardo, who headed the Mossad, Israel's national intelligence agency, under Prime Minister Benjamin Netanyahu from 2011 to ...
HONOLULU, Hawaii: U.S. Navy officials say that it would cost some $1.5 million to salvage a P-8A jet plane that ...
NEW YORK, New York - In a rare move, United Nations Secretary-General Antonio Guterres has taken a dramatic constitutional step ...
BUKITTINGGI, Indonesia: On December 2, Mount Marapi in West Sumatra province, Indonesia, erupted, sending hot ash clouds several miles (kilometers) ...
PHILADELPHIA, Pennsylvania: In a measure supporters claimed will increase public safety amid high violent crime rates, Philadelphia City Council passed ...
CHICAGO, Illinois: As winter sets in and with cold weather just around the corner, Chicago is struggling to house hundreds ...